ERBB2 and breast cancer: Acknowledging BC molecular and histological heterogeneity, all cohorts were stratified according to histological subtype—invasive carcinoma of no special type (NST) or invasive lobular carcinoma (ILC), as well as the ER and HER2 status (Table 1, Supplementary Fig. 1).